购物车
- 全部删除
- 您的购物车当前为空
HSD17B13-IN-35 (compound 76) 作为一种高效的抑制剂,针对羟基类固醇 17?-脱氢酶13 (HSD17B13) (hydroxysteroid 17?-dehydrogenase 13 (HSD17B13)),其IC50? 针对底物雌二醇小于 0.1 μM。此化合物在非酒精性脂肪肝疾病 (NAFLD),包括非酒精性脂肪性肝炎(NASH)的研究中具有显著重要性。
HSD17B13-IN-35 (compound 76) 作为一种高效的抑制剂,针对羟基类固醇 17?-脱氢酶13 (HSD17B13) (hydroxysteroid 17?-dehydrogenase 13 (HSD17B13)),其IC50? 针对底物雌二醇小于 0.1 μM。此化合物在非酒精性脂肪肝疾病 (NAFLD),包括非酒精性脂肪性肝炎(NASH)的研究中具有显著重要性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 询价 | 10-14周 | |
50 mg | 询价 | 10-14周 |
产品描述 | HSD17B13-IN-35 (compound 76) is a potent inhibitor of hydroxysteroid 17?-dehydrogenase 13 (HSD17B13), exhibiting an IC50 value of less than 0.1 μM using estradiol as the substrate. This compound is significantly relevant in the management of nonalcoholic fatty liver diseases (NAFLDs), including nonalcoholic steatohepatitis (NASH) [1]. |
分子量 | 524.33 |
分子式 | C25H16Cl2FN5O3 |
CAS No. | 2770246-69-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.